At a glance
The March 21, 2022, Clinical Laboratory COVID-19 Response (CLCR) call included antigen testing guidance update, HHS reporting requirements update, and SARS-CoV-2 testing using rapid antigen tests key findings, as well as updates from FDA.

Agenda
Welcome: Jasmine Chaitram, ÐÇ¿ÕÓéÀÖ¹ÙÍø Division of Laboratory Systems (DLS)
Antigen Testing Guidance Update: Reynolds (Ren) Salerno, ÐÇ¿ÕÓéÀÖ¹ÙÍø Division of Laboratory Systems (DLS)
HHS Reporting Requirements Update: Jason Hall, ÐÇ¿ÕÓéÀÖ¹ÙÍø Data, Analytics, and Visualization Task Force
Key Findings for SARS-CoV-2 Testing Using Rapid Antigen Tests from RADx Clinical Studies Core: Apurv Soni, University of Massachusetts Chan Medical School
FDA Update: Tim Stenzel, U.S. Food and Drug Administration (FDA)